Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hematological Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02453477
What this trial is testing

Gene Therapy for Transfusion Dependent Beta-thalassemia

Who this might be right for
Beta-Thalassemia
IRCCS San Raffaele 10
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Not applicableStudy completedNCT04731701
What this trial is testing

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

Who this might be right for
Hemophilia AHemophilia B
Swedish Orphan Biovitrum 180
Testing effectiveness (Phase 2)Study completedNCT00009581
What this trial is testing

Nitric Oxide to Improve Blood Flow in Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia
National Institutes of Health Clinical Center (CC) 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404881
What this trial is testing

Bevacizumab In Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic Telangiectasia
Hanny Al-Samkari, MD 33
Testing effectiveness (Phase 2)Study completedNCT00274807
What this trial is testing

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 40
Testing effectiveness (Phase 2)Ended earlyNCT03597022
What this trial is testing

Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors

Who this might be right for
Hemophilia A and B
Bayer 24
Not applicableLooking for participantsNCT06610201
What this trial is testing

Bleeding and Treatment in Participants With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease (VWD)Von Willebrand Disease (VWD), Type 1Von Willebrand Disease (VWD), Type 2+4 more
Hemab ApS 200
Testing effectiveness (Phase 2)Ended earlyNCT02586012
What this trial is testing

Weight-based Dosing in Hemophilia A

Who this might be right for
Hemophilia
Craig Seaman 30
Early research (Phase 1)Study completedNCT00624936
What this trial is testing

Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Ohio State University Comprehensive Cancer Center 23
Early research (Phase 1)Ended earlyNCT00100971
What this trial is testing

Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Boston Medical Center 9
Large-scale testing (Phase 3)Ended earlyNCT00387192
What this trial is testing

A Study With OPTIVATE® in People With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease
Bio Products Laboratory 26
Early research (Phase 1)Study completedNCT01439971
What this trial is testing

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

Who this might be right for
Hemophilia A
Catalyst Biosciences 29
Not applicableStudy completedNCT00004648
What this trial is testing

Studies of Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
National Center for Research Resources (NCRR) 65
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Not applicableStudy completedNCT03947632
What this trial is testing

Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia

Who this might be right for
Beta Thalassemia Major
Aga Khan University 367
Not applicableLooking for participantsNCT05871216
What this trial is testing

Functional Instability in Patients Suffering From Collagen Disease and Joint Hypermobility

Who this might be right for
Hypermobility SyndromeDanlos Disease, EhlersCollagen Diseases+2 more
Istituto Ortopedico Rizzoli 30
Not applicableStudy completedNCT03372993
What this trial is testing

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more
AryoGen Pharmed Co. 200
Not applicableWithdrawnNCT01888614
What this trial is testing

Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study

Who this might be right for
Sickle Cell Disease
University Hospitals Cleveland Medical Center
Not applicableStudy completedNCT02239016
What this trial is testing

Screening Patients With Sickle Cell Disease for Kidney Damage

Who this might be right for
Sickle Cell Disease
Children's Hospital Medical Center, Cincinnati 320
Next Page